US 12,453,519 B2
System and method for assessing and monitoring the hemodynamic condition of a patient
Ashwin Belle, Ann Arbor, MI (US); Bryce Benson, Ann Arbor, MI (US); and Mark Salamango, Ann Arbor, MI (US)
Assigned to AIRSTRIP OPERATIONS, LLC, San Antonio, TX (US)
Filed by AirStrip Operations, LLC, San Antonio, TX (US)
Filed on Feb. 8, 2024, as Appl. No. 18/436,453.
Application 18/436,453 is a continuation of application No. 16/660,408, filed on Oct. 22, 2019, granted, now 11,925,487.
Application 16/660,408 is a continuation of application No. 16/216,807, filed on Dec. 11, 2018, granted, now 10,485,489, issued on Nov. 26, 2019.
Prior Publication US 2024/0237952 A1, Jul. 18, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 5/00 (2006.01); A61B 5/024 (2006.01); A61B 5/0245 (2006.01); A61B 5/339 (2021.01); A61B 5/352 (2021.01); A61B 5/366 (2021.01)
CPC A61B 5/746 (2013.01) [A61B 5/02405 (2013.01); A61B 5/0245 (2013.01); A61B 5/339 (2021.01); A61B 5/352 (2021.01); A61B 5/366 (2021.01); A61B 5/726 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method for monitoring of a physiological condition of a patient, the method comprising:
at a computing system, receiving a physiological signal stream;
at the computing system, determining a set of labels associated with the physiological signal stream, comprising:
when a first low data quality criterion of a set of criteria is met by a portion of the physiological signal stream, assigning a first label to the portion of the physiological signal stream;
determining a set of features based on a set of waveforms of the physiological signal stream, wherein the set of features are not determined based on waveforms associated with the portion of the physiological signal stream associated with the first label;
determining a risk classification of the patient based on the set of features; and
in response to determining the risk classification, automatically initiating administration of a drug delivery to the patient at a therapeutic delivery system.